Radiation Safety Committees
Emory University Management is directly involved with the Radiation Safety Program. Management provides sufficient authority and organizational freedom to the Radiation Safety Officer and the Radiation Control Council to identify radiation safety problems, to initiate recommendations or provide solutions, and to verify implementation of corrective actions. Emory University Management at the level of Vice-President is represented on the Radiation Control Council. Members of the Radiation Control Council, Committees 1, 2 and 3, and the Radioactive Drug Research Committee (RDRC) are appointed by Emory University administration.
Radiation Safety Committee I reviews applications for human use of radioactive materials, in both research and clinical uses, as well as applications for authorized users, authorized medical physicists, and authorized nuclear pharmacists.
Radiation Safety Committee II reviews applications for non-human use of radioactive materials.
Radiation Safety Committee III reviews applications for human research using radiation from radiation producing machines.
Radioactive Drug Research Committee reviews applications for human use of radiopharmaceuticals as required by FDA regulations.
To learn more about each committee's function, membership, meetings, and duties, visit each committee's page linked above or located in the left-hand navigation.